Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Beam Radiotherapy for Unresectable Liver Metastasis: Prospective Phase II Trial

NCT04456621 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04456621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Beam Radiotherapy for Unresectable Liver Metastasis: Prospective Phase II Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
July 31, 2021
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

local control rate, side effect